page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Lichen sclerosus

Lichen sclerosus is one form of vulvar dystrophy. With lichen sclerosus, the skin of the vulva is too thin.

Clinically, women with lichen sclerosus complain of chronic vulvar itching and irritation. Tissues may be fragile, tear easily and result in superficial bleeding. Using only casual observation, the vulva may appear normal, but closer inspection will reveal a whitish discoloration and loss of anatomic differentiation of the vulvar structures.

It may be difficult, without a vulvar biopsy, to distinguish lichen sclerosus from the other forms of vulvar dystrophy (hypertrophic vulvar dystrophy and mixed dystrophy). For this reason, women suspected of having lichen sclerosus usually undergo vulvar biopsy to confirm the diagnosis.

Lichen sclerosus can occur in any age group, is not related to lack of estrogen, and its' cause is not known.

Lichen Sclerosis

Lichen Sclerosis

Strong topical steroids, such as clobetasol or betamethasone have been studied in multiple centers, and in general are probably the most effective currently-available treatment:

  • 0.05% clobetasol propionate cream is applied to the vulva twice daily for one month, than at bedtime for one month and then twice a week for three months. It is then used as needed one or two times per week. Using this approach, 95% of patients will notice significant improvement and 75% will report complete remission of symptoms.

In the past, the most effective available treatment consisted of topical testosterone. This treatment can still be effective, but the percentage of responders is less than with strong topical steroids.

  • 2% testosterone propionate in petroleum jelly, applied 3 times a day for 3 to 6 months or until the symptoms are relieved. Then the applications are gradually reduced to a level of one or two applications per week.

 


This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site